In the title compound, C 12 H 15 ClNO + ÁC 4 H 5 O 6 À , the cyclohexanone ring adopts a chair conformation. The benzene ring is significantly twisted so that it is in an almost perpendicular position to the C-N bond with a C Ar -C Ar -C-N torsion angle of À96. 5 (5) . Intermolecular N-HÁ Á ÁO and O-HÁ Á ÁO hydrogen bonds are observed in the crystal structure.
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For background to ketamine, see: Holtman (2006) ; Holtman et al. (2006) ; Heshmati et al. (2003) ; Kohrs & Durieux (1998) . For the synthesis, see: Hong & Davisson (1982) ; Parcell & Sanchez (1981) .
Experimental
Crystal data Table 1 Hydrogen-bond geometry (Å , ). Symmetry codes:
Data collection: COLLECT (Nonius, 1998 ); cell refinement: SCALEPACK (Otwinowski & Minor, 1997) ; data reduction: DENZO-SMN (Otwinowski & Minor, 1997 ); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008) ; molecular graphics: XP in SHELXTL (Sheldrick, 2008) ; software used to prepare material for publication: SHELXL97 and local procedures. , the racemic mixture of R-and S-Ketamines is becoming the sedative and anesthetic of choice for emergency sedation in children and victims with unknown medical history, e.g. from traffic accidents to battlefield conditions, because it causes minimal respiratory depression in comparison to other anesthetics (Heshmati et al., 2003) . S-Ketamine was found 3-4 times more potent as an anesthetic than its R-enantiomer, and twice as potent as Ketalar TM with fewer side effects such as psychedelic, disorientation and anxiety (Kohrs & Durieux, 1998) . S-Norketamine, the major metabolite of S-Ketamine in humans and animals, is emerging as a novel drug for treatment of neuropathic pain and for analgesia (Holtman, 2006) . To confirm the absolute configuration of (+)-norketamine, herein we report on the X-ray crystallographic characterization of crystalline S-norketamine D-tartrate salt.

S-Norketamine was obtained as a D-tartrate salt form via chiral resolution of racemic norketamine by fractional crystalliz-
ation of the D-tartrate salt (Hong & Davisson, 1982) . Racemic norketamine was produced in large quantity according to literature report (Parcell & Sanchez, 1981) . The chiral purity of the product was determined by chiral HPLC on a Chiralcel Symmetry codes: (i) −x+2, y−1/2, −z+3/2; (ii) −x+1, y−1/2, −z+3/2; (iii) −x+1, y+1/2, −z+3/2; (iv) −x+2, y+1/2, −z+3/2; (v) x+1, y, z.
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